|
| Fatal Overdoses |
| Opioid Overdose Deaths | Opioids identified as the cause of death by Florida Medical Examiners by county where death occurred. For more information regarding drugs included in this definition, please see the FDLE Drugs in Deceased Persons Reports on the Resources tab. Data source: Florida Department of Law Enforcement. |
| Drug Overdose Deaths | Drugs identified as the cause of death by Florida Medical Examiners by county where death occurred. For more information regarding drugs included in this definition, please see the FDLE Drugs in Deceased Persons Reports on the Resources tab. Data source: Florida Department of Law Enforcement. |
| Opioid Overdose Annual Age-Adjusted Death Rate | Opioids identified as the cause of death by Florida Medical Examiners by county where death occurred. For more information regarding drugs included in this definition, please see the FDLE Drugs in Deceased Persons Reports on the Resources tab. Data source: Florida Department of Law Enforcement. |
| Drug Overdose Annual Age-Adjusted Death Rate | Drugs identified as the cause of death by Florida Medical Examiners by county where death occurred. For more information regarding drugs included in this definition, please see the FDLE Drugs in Deceased Persons Reports on the Resources tab. Data source: Florida Department of Law Enforcement. |
| Emergency Medical Service Responses to Drug Overdoses |
| Emergency Medical Service Responses to a Suspected Opioid-involved Overdose | Patients with an identified opioid overdose during an emergency medical service transport. Data source: Florida Department of Health, EMSTARS. |
| Emergency Medical Service Responses to a Suspected Drug Overdose Including Opioids | Patients with an identified drug overdose (opioids or other drugs) during an emergency medical service transport. Data source: Florida Department of Health, EMSTARS. |
| Naloxone Administered | Naloxone medication administered by Emergency Medical Services (EMS), prior to EMS arrival, or administration noted as not applicable or not recorded. Cases/incidents represented are not mutually exclusive. A case could both be administered naloxone by EMS and prior to EMS, and would be represented in both categories. Data does not reflect the dosage, only whether or not naloxone was administrated by a unique party (EMS or prior to EMS). Data source: Florida Department of Health, EMSTARS |
| All Drug Non-fatal Overdose Emergency Department Visits |
| All Drug Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department visits (ED) with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 960-979, E850-E858, E905.0-E950.5, E962.0, E980.0-E980.5. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T36-T50 that have a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent (except for T36.9, T37.9, T39.9, T41.4, T42.7, T43.9, T45.9, T47.9, and T49.9 where 5th character indicating unintentional, intentional self-harm, assault, and undetermined intent) and a 7th character indicating an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/Undetermined Non-fatal Drug Overdose Emergency Department Visits | Non-fatal emergency department visits with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 960-979, E850-E858, E905.0-E950.5, E962.0, E980.0-E980.5. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T36-T50 that have a 6th character indicating unintentional or undetermined intent (except for T36.9, T37.9, T39.9, T41.4, T42.7, T43.9, T45.9, T47.9, and T49.9 where 5th character indicating unintentional or undetermined intent) and a 7th character indicating an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Intentional Self-harm Non-fatal Drug Overdose Emergency Department Visits | Non-fatal emergency department visits with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: E905.0-E950.5. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T36-T50 that have a 6th character indicating intentional self-harm intent (except for T36.9, T37.9, T39.9, T41.4, T42.7, T43.9, T45.9, T47.9, and T49.9 where 5th character indicating intentional self-harm intent) and a 7th character indicating an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Opioid-Involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department (ED) visits with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.00, 965.01, 965.02, 965.09, E850.0, E850.1 or E850.2. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.0X, T40.1X, T40.2X, T40.3X, T40.4X, T40.60 or T40.69 with a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent and a 7th character indicating that this is an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/Undetermined Non-fatal Opioid-involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department visits with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.00, 965.01, 965.02, 965.09, E850.0, E850.1 or E850.2. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.0X, T40.1X, T40.2X, T40.3X, T40.4X, T40.60 or T40.69 with a 6th character indicating unintentional or undetermined intent and a 7th character indicating that this is an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Intentional Self-harm Non-fatal Opioid-involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department visits with the following ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.0X, T40.1X, T40.2X, T40.3X, T40.4X, T40.60 or T40.69 with a 6th character indicating intentional self-harm intent and a 7th character indicating that this is an initial encounter. Intentional self-harm ICD-9-CM codes specific to this indicator are not available. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Heroin-Involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department (ED) visits with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.01, E850.0. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.1X with a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent and a 7th character indicating that this is an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/undetermined Non-fatal Heroin-involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department visits with either of the following: ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.01, E850.0. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.1X with a 6th character indicating unintentional or undetermined intent and a 7th character indicating that this is an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Intentional Self-harm Non-fatal Heroin-involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department visits with the following ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.1X with a 6th character indicating intentional self-harm intent and a 7th character indicating that this is an initial encounter. Intentional self-harm ICD-9-CM codes specific to this indicator are not available. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Stimulant-involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department (ED) visits with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 969.70, 969.71, 969.72, 969.73, 969.79, 970.0, 970.81, 970.89, 970.9, E854.2, E854.3, E855.2 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.5X, T43.60, T43.61, T43.62, T43.63, T43.64, T43.69 with a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent and a 7th character indicating that this is an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/Undetermined Non-fatal Stimulant-involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department visits with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 969.70, 969.71, 969.72, 969.73, 969.79, 970.0, 970.81, 970.89, 970.9, E854.2, E854.3, E855.2 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.5X, T43.60, T43.61, T43.62, T43.63, T43.64, T43.69 with a 6th character indicating unintentional or undetermined intent and a 7th character indicating that this is an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM andICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Intentional Self-harm Non-fatal Stimulant-involved Non-fatal Overdose Emergency Department Visits | Non-fatal emergency department visits with the following ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.5X, T43.60, T43.61, T43.62, T43.63, T43.64, T43.69 with a 6th character indicating intentional self-harm intent and a 7th character indicating that this is an initial encounter. Intentional self-harm ICD-9-CM codes specific to this indicator are not available. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). ED record data before October 2015 useICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM andICD-10-CM should not be compared as these coding systems are different from each other. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| All Drug Non-fatal Overdose Hospitalizations |
| All Drug Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 960-979, E850-E858, E905.0-E950.5, E962.0, E980.0-E980.5. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T36-T50 that have a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent (except for T36.9, T37.9, T39.9, T41.4, T42.7, T43.9, T45.9, T47.9, and T49.9 where 5th character indicating unintentional, intentional self-harm, assault, and undetermined intent) and a 7th character indicating an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/Undetermined Non-fatal Drug Overdose Hospitalizations | Non-fatal hospitalizations either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 960-979, E850-E858, E980.0-E980.5. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T36-T50 that have a 6th character indicating unintentional or undetermined intent (except for T36.9, T37.9, T39.9, T41.4, T42.7, T43.9, T45.9, T47.9, and T49.9 where 5th character indicating unintentional or undetermined intent) and a 7th character indicating an initial encounter. Data supplied by the Florida Agency for Health Care Administration (AHCA). Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. |
| Intentional Self-harm Non-fatal Drug Overdose Hospitalizations | Non-fatal hospitalizations either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: E905.0-E950.5. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T36-T50 that have a 6th character indicating intentional self-harm intent (except for T36.9, T37.9, T39.9, T41.4, T42.7, T43.9, T45.9, T47.9, and T49.9 where 5th character indicating intentional self-harm intent) and a 7th character indicating an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Opioid-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.00, 965.01, 965.02 or 965.09, E850.0, E850.1 or E850.2. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.0X, T40.1X, T40.2X, T40.3X, T40.4X, T40.60 or T40.69 with a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent and a 7th character indicating that this is an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/Undetermined Non-fatal Opioid-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.00, 965.01, 965.02, 965.09, E850.0, E850.1 or E850.2. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.0X, T40.1X, T40.2X, T40.3X, T40.4X, T40.60 or T40.69 with a 6th character indicating unintentional or undetermined intent and a 7th character indicating that this is an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1,2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Intentional Self-harm Non-fatal Opioid-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with either of the following: ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.0X, T40.1X, T40.2X, T40.3X, T40.4X, T40.60 or T40.69 with a 6th character indicating intentional self-harm intent and a 7th character indicating that this is an initial encounter. Intentional self-harm ICD-9-CM codes specific to this indicator are not available. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1,2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Heroin-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with either of the following: 1) ICD-9-CM diagnosis codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.01, E850.0. 2) ICD-10-CM diagnosis codes listed in the primary or secondary diagnoses fields: T40.1X with a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent and a 7th character indicating that this is an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/Undetermined Non-fatal Heroin-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with either of the following: ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 965.01, E850.0. 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.1X with a 6th character indicating unintentional or undetermined intent and a 7th character indicating that this is an initial encounter. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Intentional Self-harm Non-fatal Heroin-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with the following ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.1X with a 6th character indicating intentional self-harm intent and a 7th character indicating that this is an initial encounter. Intentional self-harm ICD-9-CM codes specific to this indicator are not available. Counts <5 and year-to-date are suppressed. Non-fatal hospitalizations and ED visit indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). ED record data before October 2015 use ICD-9-CM; starting in October 2015, ED data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CM should not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Stimulant-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 969.70, 969.71, 969.72, 969.73, 969.79, 970.0, 970.81, 970.89, 970.9, E854.2, E854.3, E855.2 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.5X, T43.60, T43.61, T43.62, T43.63, T43.64, T43.69 with a 6th character indicating unintentional, intentional self-harm, assault, or undetermined intent and a 7th character indicating that this is an initial encounter. Counts less than 5 are suppressed. Non-fatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10th Revision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Unintentional/Undetermined Non-fatal Stimulant-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with either of the following: 1) ICD-9-CM codes listed in the primary diagnosis, secondary diagnosis, or external cause fields: 969.70, 969.71, 969.72, 969.73, 969.79, 970.0, 970.81, 970.89, 970.9, E854.2, E854.3, E855.2 2) ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.5X, T43.60, T43.61, T43.62, T43.63, T43.64, T43.69 with a 6th character indicating unintentional or undetermined intent and a 7th character indicating that this is an initial encounter. Counts <5 and year-to-date are suppressed. Nonfatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CMshould not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Intentional Self-harm Non-fatal Stimulant-involved Non-fatal Overdose Hospitalizations | Non-fatal hospitalizations with the following ICD-10-CM codes listed in the primary or secondary diagnoses fields: T40.5X, T43.60, T43.61, T43.62, T43.63, T43.64, T43.69 with a 6th character indicating intentional self-harm intent and a 7th character indicating that this is an initial encounter. Intentional self-harm ICD-9-CM codes specific to this indicator are not available. Counts <5 and year-to-date are suppressed. Nonfatal hospitalizations and ED visits indicators are not mutually exclusive as more than one type of drug may be listed. Effective October 1, 2015, the ICD 9th Revision Clinical Modification (ICD-9-CM) transitioned to ICD 10thRevision Clinical Modification (ICD-10-CM). Hospital record data before October 2015 use ICD-9-CM; starting in October 2015, hospital data use ICD-10-CM. Consequently, increases or decreases starting in 2015 may not be due to changes in disease trends but due to changes in coding. Trends between ICD-9-CM and ICD-10-CMshould not be compared as these coding systems are different from each other. Veteran Affairs (VA) and other federal hospitals, rehabilitation centers, residential treatment facilities, and psychiatric hospitals are excluded. County level results are based on county of residence. For more information regarding drugs included in this definition, please see the CSTE Guidance Document on the Resources tab. Data source: Florida Agency for Health Care Administration (AHCA). |
| Poison Information Network Calls |
| Florida Poison Information Network Calls Related to Opioids | Calls to the Florida Poison Information Center Network (FPICN) after exposure to prescription opioids, opioid combinations with other drugs (e.g., acetaminophen, antihistamine, aspirin), and heroin. The data were extracted from the statewide data system, ToxSentry® Web Query Builder. Exposure calls with medical outcomes listed as nontoxic exposure, unrelated health effect, and confirmed non-exposure were excluded. Call data are based upon information provided by the patient or treating health care professional. All calls to the FPICN were assessed, managed, and coded by specialists (pharmacists, nurses, physicians, or physician assistants) who are trained and certified to operate the FPICN hotline. Data source: Florida Department of Health, ToxSentry® Web Query Builder |
| Prescription and Patient Measures |
| Opioids | |
| Number of Prescriptions Dispensed | Opioid prescriptions dispensed in Florida by dispenser’s county. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Patients | Patients with opioid prescriptions that were dispensed in Florida regardless of the prescriber’s location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Prescribers | Prescribers with opioid prescriptions dispensed in Florida regardless of practice location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Patient | Opioid prescriptions dispensed from prescribers per number of unique patients. The annual rate is calculated as the total number of SII-SIV opioid prescriptions dispensed divided by the number of FL patients aged 18 and over who received at least one SII-SIV opioid prescription in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Prescriber | Opioid prescriptions dispensed per number of unique prescribers. The annual rate is calculated as the total number of SII-SIV opioid prescriptions dispensed divided by the number of prescribers who wrote at least one SII-SIV opioid prescription to FL patients aged 18 and over in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Stimulants | |
| Number of Prescriptions Dispensed | Stimulant prescriptions dispensed in Florida by dispenser’s county. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Patients | Patients with stimulant prescriptions that were dispensed in Florida regardless of the prescriber’s location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Prescribers | Prescribers with stimulant prescriptions dispensed in Florida regardless of practice location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Patient | Stimulant prescriptions dispensed from prescribers per number of unique patients. The annual rate is calculated as the total number of stimulant prescriptions dispensed divided by the number of FL patients aged 18 and over who received at least one stimulant prescription in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Prescriber | Stimulant prescriptions dispensed per number of unique prescribers. The annual rate is calculated as the total number of SII-SIV opioid prescriptions dispensed divided by the number of prescribers who wrote at least one SII-SIV opioid prescription to FL patients aged 18 and over in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Benzodiazepines | |
| Number of Prescriptions Dispensed | Benzodiazepines prescriptions dispensed in Florida by dispenser’s county. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Patients | Patients with benzodiazepine prescriptions that were dispensed in Florida regardless of the prescriber’s location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Prescribers | Prescribers with benzodiazepine prescriptions dispensed in Florida regardless of practice location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Patient | Benzodiazepine prescriptions dispensed from prescribers per number of unique patients. The annual rate is calculated as the total number of benzodiazepine prescriptions dispensed divided by the number of FL patients aged 18 and over who received at least one benzodiazepine prescription in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Prescriber | Benzodiazepine prescriptions dispensed per number of unique prescribers. The annual rate is calculated as the total number of benzodiazepine prescriptions dispensed divided by the number of prescribers who wrote at least one benzodiazepine prescription to FL patients aged 18 and over in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Muscle Relaxants | |
| Number of Prescriptions Dispensed | Muscle relaxant prescriptions dispensed in Florida by dispenser’s county. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Patients | Patients with muscle relaxant prescriptions that were dispensed in Florida regardless of the prescriber’s location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Number of Unique Prescribers | Prescribers with muscle relaxant prescriptions dispensed in Florida regardless of practice location by dispenser’s county. For the year to date sums, the calculations reflect the total of unique cases (unique patients, unique prescribers, etc.). The numbers from one quarter to the next may reflect overlapping cases, which are not counted in the sum total. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Patient | Muscle relaxant prescriptions dispensed from prescribers per number of unique patients. The annual rate is calculated as the total number of muscle relaxant prescriptions dispensed divided by the number of FL patients aged 18 and over who received at least one muscle relaxant prescription in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Prescriptions Dispensed per Prescriber | Muscle relaxant prescriptions dispensed per number of unique prescribers. The annual rate is calculated as the total number of muscle relaxant prescriptions dispensed divided by the number of prescribers who wrote at least one muscle relaxant prescription to FL patients aged 18 and over in the given year. Data Source: Florida Department of Health, Prescription Drug Monitoring Program. |
| Arrests |
| Annual Drug Arrests | Arrests attributed to possession or sale of illegal drugs. Data source: Florida Department of Law Enforcement. |
| Annual Adult Drug Arrests | Arrests of persons 18 and over attributed to possession or sale of illegal drugs. Data source: Florida Department of Law Enforcement. |
| Annual Juvenile Drug Arrests | Arrests of persons under 18 attributed to possession or sale of illegal drugs. Data source: Florida Department of Law Enforcement. |
| Motor Vehicle Traffic Crashes |
| Alcohol Confirmed Motor Vehicle Traffic Crashes | A crash involving a driver and/or non-motorist who had a blood alcohol content greater than 0.00. This excludes drug confirmed individuals. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report. |
| Alcohol Confirmed Motor Vehicle Traffic Crash Fatalities | The death of a person as a direct result of a crash involving a driver and/or non-motorist who had a blood alcohol content greater than 0.00. This excludes drug confirmed individuals. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report. |
| Alcohol Confirmed Motor Vehicle Traffic Crash Injuries | Non-fatal injury of a person as a direct result of a crash involving a driver and/or non-motorist who had a blood alcohol content greater than 0.00. This excludes drug confirmed individuals. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report. |
| Drug Confirmed Motor Vehicle Traffic Crashes | A crash involving a driver and/or non-motorist who tested positive for drugs at the time of the crash. This excludes alcohol confirmed individuals. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report |
| Drug Confirmed Motor Vehicle Traffic Crash Fatalities | The death of a person as a direct result of a crash involving a driver and/or non-motorist who tested positive for drugs at the time of the crash. This excludes alcohol confirmed individuals. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report. |
| Drug Confirmed Motor Vehicle Traffic Crash Injuries | Non-fatal injury of a person as a direct result of a crash involving a driver and/or non-motorist who tested positive for drugs at the time of the crash. This excludes alcohol confirmed individuals. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report. |
| Drug and Alcohol Confirmed Motor Vehicle Traffic Crashes | A crash involving a driver and/or non-motorist who had both a blood alcohol content greater than 0.00 and a positive drug test. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report |
| Drug and Alcohol Confirmed Motor Vehicle Traffic Crash Fatalities | The death of a person as a direct result of a crash involving a driver and/or non-motorist who had both a blood alcohol content greater than 0.00 and a positive drug test. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report. |
| Drug and Alcohol Confirmed Motor Vehicle Traffic Crash Injuries | Non-fatal injury of a person as a direct result of a crash involving a driver and/or non-motorist who had both a blood alcohol content greater than 0.00 and a positive drug test. Data source: Florida Department of Highway Safety and Motor Vehicles, Traffic Crash Facts Annual Report. |
| Health Outcomes |
| Neonatal Abstinence Syndrome | Infants less than 28 days old who were exposed to opioid prescription or illicit drugs during the mother’s pregnancy. Neonatal Abstinence Syndrome (NAS) Case Counts are reported two years after birth due to certification requirements, data linkage processes for deduplication of records and alignment with the NAS Case Definition. Data Source: Florida Department of Health, Birth Defects Registry. |
| Neonatal Abstinence Syndrome Annual Rate | Neonatal Abstinence Syndrome cases per 10,000 live births. Data Source: Florida Department of Health, Birth Defects Registry. |
| Early Steps Clients Experiencing Neonatal Abstinence Syndrome | Infants and toddlers (birth to thirty-six months) served by Florida Early Steps program that have been identified as having neonatal abstinence syndrome (ICD10 Codes P84, P91.0,P91.2,P91.4,P96,1). Data Source: Florida Department of Health, Early Steps. |
| Health Services |
| Adult Substance Abuse Beds | The number of beds indicates the number of adults (age 18+ years) who may concurrently receive substance abuse treatment on an in-patient basis. Data source: Agency for Health Care Administration (AHCA). |
| Substance Abuse Program Enrollees - Adult | Adults (ages 18+ years) who are enrolled in substance abuse treatment services. Data source: Florida Department of Children and Families. |
| Substance Abuse Program Enrollees - Children | Children (less than 18 years of age) who are enrolled in substance abuse treatment services. Data source: Florida Department of Children and Families. |